UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 10, 2018

 

AXOGEN, INC.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

 

Minnesota

   

001-36046

   

41-1301878

(State or other jurisdiction of
incorporation)

 

(Commission File Number)

 

(IRS Employer Identification
No.)

 

13631 Progress Boulevard, Suite 400,

   

 

Alachua, Florida

 

32615

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code

 

 

    

(386) 462-6800

    

 

 

 

(Former name or former address if changed since last report,)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 


 

Item 1.01 Entry into a Material Definitive Agreement.

 

AxoGen Corporation, a Delaware corporation and a wholly owned subsidiary of AxoGen, Inc. (“AC”),  and SNH Medical Office Properties Trust, a Maryland real estate investment trust (“SNH”), are parties to that certain lease dated as of February 6, 2007, as amended, (the “Lease”) pursuant to which AC leases its 11,761 square foot corporate headquarters facility in Alachua, Florida (the “Current Premises”). On April 10, 2018, AC delivered to SNH a Current Premises Election Notice (as defined in the Lease), thereby exercising its right and option under the Lease to extend the Term (as defined in the Lease) with respect to the Current Premises, or the Current Premises Term (as defined in the Lease), for one (1) period commencing November 1, 2018 and ending on October 31, 2019.

 

Item 9.01. Financial Statements and Exhibits

 

(d)    Exhibits

 

 

 

 

Exhibit No.

   

Description

10.1

 

Current Premises Election Notice dated as of April  10, 2018.

 

 

2


 

EXHIBIT INDEX

 

 

 

 

Exhibit No.

   

Description

10.1

 

Current Premises Election Notice dated as of April 10, 2018.

 

3


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

     

AXOGEN, INC.

 

 

 

 

 

 

Date: April 13, 2018

By:

/s/ Gregory G. Freitag

 

 

Gregory G. Freitag

 

 

General Counsel & Senior VP of Business Development

 

4